Upgrades
- For SolarEdge Technologies Inc (NASDAQ:SEDG), Northland Capital Markets upgraded the previous rating of Underperform to Market Perform. In the third quarter, SolarEdge Technologies showed an EPS of $0.91, compared to $1.45 from the year-ago quarter. At the moment, the stock has a 52-week-high of $375.90 and a 52-week-low of $190.15. SolarEdge Technologies closed at $211.30 at the end of the last trading period.
- According to Scotiabank, the prior rating for Delek US Holdings Inc (NYSE:DK) was changed from Sector Underperform to Sector Perform. Delek US Hldgs earned $0.02 in the third quarter, compared to $0.13 in the year-ago quarter. The stock has a 52-week-high of $35.23 and a 52-week-low of $14.71. At the end of the last trading period, Delek US Hldgs closed at $33.62.
- According to William Blair, the prior rating for Stratasys Ltd (NASDAQ:SSYS) was changed from Underperform to Market Perform. Stratasys earned $0.02 in the second quarter, compared to $0.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of $28.00 and a 52-week-low of $12.69. Stratasys closed at $13.67 at the end of the last trading period.
- According to Goldman Sachs, the prior rating for Mettler-Toledo International Inc (NYSE:MTD) was changed from Sell to Neutral. Mettler-Toledo Intl earned $10.18 in the third quarter, compared to $8.72 in the year-ago quarter. The current stock performance of Mettler-Toledo Intl shows a 52-week-high of $1699.11 and a 52-week-low of $1065.55. Moreover, at the end of the last trading period, the closing price was at $1298.71.
- Morgan Stanley upgraded the previous rating for Southern Copper Corp (NYSE:SCCO) from Equal-Weight to Overweight. Southern Copper earned $0.56 in the second quarter, compared to $1.21 in the year-ago quarter. At the moment, the stock has a 52-week-high of $79.31 and a 52-week-low of $42.42. Southern Copper closed at $53.04 at the end of the last trading period.
- According to Deutsche Bank, the prior rating for Dave & Buster's Entertainment Inc (NASDAQ:PLAY) was changed from Hold to Buy. For the second quarter, Dave & Buster's Enter had an EPS of $0.64, compared to year-ago quarter EPS of $1.07. The current stock performance of Dave & Buster's Enter shows a 52-week-high of $52.54 and a 52-week-low of $29.60. Moreover, at the end of the last trading period, the closing price was at $37.05.
- Piper Sandler upgraded the previous rating for 2U Inc (NASDAQ:TWOU) from Underweight to Neutral. For the third quarter, 2U had an EPS of $0.05, compared to year-ago quarter EPS of $0.23. The stock has a 52-week-high of $20.98 and a 52-week-low of $4.70. At the end of the last trading period, 2U closed at $6.36.
- According to Macquarie, the prior rating for Block Inc (NYSE:SQ) was changed from Neutral to Outperform. For the third quarter, Block had an EPS of $0.42, compared to year-ago quarter EPS of $0.37. At the moment, the stock has a 52-week-high of $165.20 and a 52-week-low of $51.34. Block closed at $62.67 at the end of the last trading period.
- For Viatris Inc (NASDAQ:VTRS), Piper Sandler upgraded the previous rating of Underweight to Neutral. Viatris earned $0.87 in the third quarter, compared to $0.99 in the year-ago quarter. At the moment, the stock has a 52-week-high of $15.60 and a 52-week-low of $8.42. Viatris closed at $10.97 at the end of the last trading period.
- According to Stifel, the prior rating for Global Partners LP (NYSE:GLP) was changed from Hold to Buy. In the third quarter, Global Partners showed an EPS of $3.12, compared to $0.86 from the year-ago quarter. At the moment, the stock has a 52-week-high of $35.29 and a 52-week-low of $20.23. Global Partners closed at $29.96 at the end of the last trading period.
- According to Barclays, the prior rating for The Scotts Miracle Gro Co (NYSE:SMG) was changed from Equal-Weight to Overweight. Scotts Miracle Gro earned $2.04 in the fourth quarter, compared to $0.82 in the year-ago quarter. At the moment, the stock has a 52-week-high of $167.09 and a 52-week-low of $39.05. Scotts Miracle Gro closed at $51.71 at the end of the last trading period.
See all analyst ratings upgrades.
Downgrades
- For Huntsman Corp (NYSE:HUN), Tudor Pickering downgraded the previous rating of Buy to Hold. Huntsman earned $0.71 in the third quarter, compared to $1.08 in the year-ago quarter. The current stock performance of Huntsman shows a 52-week-high of $41.65 and a 52-week-low of $23.54. Moreover, at the end of the last trading period, the closing price was at $26.72.
- Wolfe Research downgraded the previous rating for JELD-WEN Holding Inc (NYSE:JELD) from Peer Perform to Underperform. JELD-WEN Holding earned $0.71 in the third quarter, compared to $0.45 in the year-ago quarter. The stock has a 52-week-high of $27.59 and a 52-week-low of $8.38. At the end of the last trading period, JELD-WEN Holding closed at $9.46.
- Truist Securities downgraded the previous rating for WM Technology Inc (NASDAQ:MAPS) from Buy to Hold. WM Tech earned $0.06 in the third quarter, compared to $0.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of $8.35 and a 52-week-low of $1.58. WM Tech closed at $1.93 at the end of the last trading period.
- For Marsh & McLennan Companies Inc (NYSE:MMC), Atlantic Equities downgraded the previous rating of Overweight to Neutral. In the third quarter, Marsh & McLennan showed an EPS of $1.18, compared to $1.08 from the year-ago quarter. The stock has a 52-week-high of $183.14 and a 52-week-low of $142.80. At the end of the last trading period, Marsh & McLennan closed at $163.01.
- According to Deutsche Bank, the prior rating for Adient PLC (NYSE:ADNT) was changed from Buy to Hold. In the fourth quarter, Adient showed an EPS of $0.53, compared to $0.24 from the year-ago quarter. The stock has a 52-week-high of $50.96 and a 52-week-low of $27.15. At the end of the last trading period, Adient closed at $38.37.
- Chardan Capital downgraded the previous rating for Oyster Point Pharma Inc (NASDAQ:OYST) from Buy to Neutral. In the second quarter, Oyster Point Pharma showed an EPS of $1.87, compared to $0.85 from the year-ago quarter. The current stock performance of Oyster Point Pharma shows a 52-week-high of $18.30 and a 52-week-low of $3.46. Moreover, at the end of the last trading period, the closing price was at $11.57.
- B of A Securities downgraded the previous rating for Ritchie Bros Auctioneers Inc (NYSE:RBA) from Buy to Neutral. In the third quarter, Ritchie Bros Auctioneers showed an EPS of $0.53, compared to $0.45 from the year-ago quarter. The current stock performance of Ritchie Bros Auctioneers shows a 52-week-high of $72.73 and a 52-week-low of $48.65. Moreover, at the end of the last trading period, the closing price was at $51.29.
- For Ouster Inc (NYSE:OUST), Baird downgraded the previous rating of Outperform to Neutral. In the third quarter, Ouster showed an EPS of $0.20, compared to $0.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $5.54 and a 52-week-low of $0.76. Ouster closed at $1.21 at the end of the last trading period.
- Wedbush downgraded the previous rating for Williams-Sonoma Inc (NYSE:WSM) from Outperform to Neutral. In the second quarter, Williams-Sonoma showed an EPS of $3.87, compared to $3.24 from the year-ago quarter. The current stock performance of Williams-Sonoma shows a 52-week-high of $176.89 and a 52-week-low of $101.58. Moreover, at the end of the last trading period, the closing price was at $123.47.
- According to Raymond James, the prior rating for ICU Medical Inc (NASDAQ:ICUI) was changed from Outperform to Market Perform. In the third quarter, ICU Medical showed an EPS of $1.75, compared to $2.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $251.73 and a 52-week-low of $132.75. ICU Medical closed at $142.07 at the end of the last trading period.
- According to Deutsche Bank, the prior rating for Jack In The Box Inc (NASDAQ:JACK) was changed from Buy to Hold. In the third quarter, Jack In The Box showed an EPS of $1.38, compared to $1.79 from the year-ago quarter. The stock has a 52-week-high of $96.87 and a 52-week-low of $54.80. At the end of the last trading period, Jack In The Box closed at $86.07.
- Piper Sandler downgraded the previous rating for Q2 Holdings Inc (NYSE:QTWO) from Neutral to Underweight. Q2 Holdings earned $0.10 in the third quarter, compared to $0.03 in the year-ago quarter. The current stock performance of Q2 Holdings shows a 52-week-high of $81.56 and a 52-week-low of $25.53. Moreover, at the end of the last trading period, the closing price was at $26.44.
- For Benefitfocus Inc (NASDAQ:BNFT), Keybanc downgraded the previous rating of Overweight to Sector Weight. For the third quarter, Benefitfocus had an EPS of $0.12, compared to year-ago quarter EPS of $0.19. At the moment, the stock has a 52-week-high of $13.05 and a 52-week-low of $5.68. Benefitfocus closed at $10.40 at the end of the last trading period.
- According to Piper Sandler, the prior rating for Oyster Point Pharma Inc (NASDAQ:OYST) was changed from Overweight to Neutral. For the second quarter, Oyster Point Pharma had an EPS of $1.87, compared to year-ago quarter EPS of $0.85. The stock has a 52-week-high of $18.30 and a 52-week-low of $3.46. At the end of the last trading period, Oyster Point Pharma closed at $11.57.
- For Q2 Holdings Inc (NYSE:QTWO), RBC Capital downgraded the previous rating of Outperform to Sector Perform. Q2 Holdings earned $0.10 in the third quarter, compared to $0.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $81.56 and a 52-week-low of $25.53. Q2 Holdings closed at $26.44 at the end of the last trading period.
- For Arcosa Inc (NYSE:ACA), Stephens & Co. downgraded the previous rating of Overweight to Equal-Weight. Arcosa earned $0.70 in the third quarter, compared to $0.57 in the year-ago quarter. The stock has a 52-week-high of $65.80 and a 52-week-low of $43.42. At the end of the last trading period, Arcosa closed at $59.32.
- According to Evercore ISI Group, the prior rating for Lyft Inc (NASDAQ:LYFT) was changed from Outperform to In-Line. For the third quarter, Lyft had an EPS of $0.10, compared to year-ago quarter EPS of $0.05. The stock has a 52-week-high of $46.64 and a 52-week-low of $10.82. At the end of the last trading period, Lyft closed at $14.14.
- Jefferies downgraded the previous rating for Six Flags Entertainment Corp (NYSE:SIX) from Buy to Hold. In the second quarter, Six Flags Entertainment showed an EPS of $0.68, compared to $0.81 from the year-ago quarter. The stock has a 52-week-high of $47.24 and a 52-week-low of $16.83. At the end of the last trading period, Six Flags Entertainment closed at $21.16.
- Jefferies downgraded the previous rating for IAA Inc (NYSE:IAA) from Buy to Hold. IAA earned $0.45 in the third quarter, compared to $0.52 in the year-ago quarter. The current stock performance of IAA shows a 52-week-high of $51.12 and a 52-week-low of $31.32. Moreover, at the end of the last trading period, the closing price was at $38.42.
See all analyst ratings downgrades.
Initiations
- Deutsche Bank initiated coverage on Planet Labs PBC (NYSE:PL) with a Buy rating. The price target for Planet Labs is set to $7.00. Planet Labs earned $0.15 in the second quarter, compared to $0.46 in the year-ago quarter. The current stock performance of Planet Labs shows a 52-week-high of $7.51 and a 52-week-low of $3.70. Moreover, at the end of the last trading period, the closing price was at $5.40.
- Deutsche Bank initiated coverage on BlackSky Technology Inc (NYSE:BKSY) with a Buy rating. The price target for BlackSky Technology is set to $3.00. In the third quarter, BlackSky Technology showed an EPS of $0.11, compared to $0.67 from the year-ago quarter. The stock has a 52-week-high of $5.01 and a 52-week-low of $1.00. At the end of the last trading period, BlackSky Technology closed at $1.80.
- Raymond James initiated coverage on Kymera Therapeutics Inc (NASDAQ:KYMR) with a Market Perform rating. For the third quarter, Kymera Therapeutics had an EPS of $0.79, compared to year-ago quarter EPS of $0.56. At the moment, the stock has a 52-week-high of $65.44 and a 52-week-low of $13.15. Kymera Therapeutics closed at $29.04 at the end of the last trading period.
- For ASML Holding NV (NASDAQ:ASML), Morgan Stanley initiated coverage, by setting the current rating at Overweight. In the third quarter, ASML Holding showed an EPS of $4.32, compared to $5.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $799.36 and a 52-week-low of $363.15. ASML Holding closed at $483.39 at the end of the last trading period.
- With a Buy rating, Canaccord Genuity initiated coverage on Passage Bio Inc (NASDAQ:PASG). The price target seems to have been set at $8.00 for Passage Bio. For the second quarter, Passage Bio had an EPS of $0.73, compared to year-ago quarter EPS of $0.90. The stock has a 52-week-high of $6.55 and a 52-week-low of $1.15. At the end of the last trading period, Passage Bio closed at $1.20.
- Canaccord Genuity initiated coverage on Rocket Pharmaceuticals Inc (NASDAQ:RCKT) with a Buy rating. The price target for Rocket Pharmaceuticals is set to $53.00. In the third quarter, Rocket Pharmaceuticals showed an EPS of $0.87, compared to $0.79 from the year-ago quarter. The current stock performance of Rocket Pharmaceuticals shows a 52-week-high of $24.18 and a 52-week-low of $7.57. Moreover, at the end of the last trading period, the closing price was at $16.24.
- With a Buy rating, Canaccord Genuity initiated coverage on Generation Bio Co (NASDAQ:GBIO). The price target seems to have been set at $9.00 for Generation Bio. For the third quarter, Generation Bio had an EPS of $0.53, compared to year-ago quarter EPS of $0.56. At the moment, the stock has a 52-week-high of $9.59 and a 52-week-low of $3.96. Generation Bio closed at $6.47 at the end of the last trading period.
- Canaccord Genuity initiated coverage on Tenaya Therapeutics Inc (NASDAQ:TNYA) with a Buy rating. The price target for Tenaya Therapeutics is set to $21.00. Tenaya Therapeutics earned $0.69 in the second quarter, compared to $13.26 in the year-ago quarter. The stock has a 52-week-high of $19.45 and a 52-week-low of $1.90. At the end of the last trading period, Tenaya Therapeutics closed at $1.92.
- JonesTrading initiated coverage on HCW Biologics Inc (NASDAQ:HCWB) with a Buy rating. The price target for HCW Biologics is set to $8.00. HCW Biologics earned $0.11 in the third quarter, compared to $0.14 in the year-ago quarter. At the moment, the stock has a 52-week-high of $3.32 and a 52-week-low of $1.76. HCW Biologics closed at $2.28 at the end of the last trading period.
- With a Buy rating, Canaccord Genuity initiated coverage on Taysha Gene Therapies Inc (NASDAQ:TSHA). The price target seems to have been set at $16.00 for Taysha Gene Therapies. In the third quarter, Taysha Gene Therapies showed an EPS of $0.64, compared to $1.35 from the year-ago quarter. The current stock performance of Taysha Gene Therapies shows a 52-week-high of $12.17 and a 52-week-low of $1.35. Moreover, at the end of the last trading period, the closing price was at $2.00.
